New AI Technology From ImpriMed Helps Improve Cancer Treatment Success Rates in Your Practice…and Fosters Better Relationships

June 9, 2023

This article was published in Innovative Veterinary Care Journal.

---

CHOOSE THE RIGHT TREATMENT, RIGHT AWAY

Successful cancer treatment relies on using the right medications from the start, rather than a trial-and-error approach that wastes precious time and incurs extra costs for your clients. ImpriMed offers individualized drug response prediction profiles for animals suffering from lymphoma and leukemia. Samples are collected via proprietary transport media tubes, and the profile will be in your hands within three to seven days after that.

IMPRIMED’S DRUG RESPONSE PREDICTION PROFILE

The drug response prediction profile is based on insights gathered from multiple sources of data. Chemosensitivity and patient information are used to curate these drug response predictions. Most importantly, an ingenious robotic machine drops drugs onto the live cells as part of their ex vivo assay platform that measures the effect of cancer drugs on the live patient cells. The profile not only contains information about the most suitable drugs, but their expected response times as well. The result is a highly detailed drug prediction profile that can help achieve remission — without beating around the bush.

OTHER SERVICES

ImpriMed offers additional services such as immuno-profiling using flow cytometry and PCR for antigen receptor rearrangements, flow cytometry only, and PCR for antigen receptor rearrangements only. ImpriMed is also currently providing free immuno-profiles for cats suffering from lymphoma or leukemia.

Studies establishing the authenticity of ImpriMed’s drug response prediction profile are published in reputable science journals.

CLIENT SATISFACTION AND INCOME POTENTIAL

With ImpriMed, you will be leveling up your practice. It can be used to your advantage by yielding better clinical outcomes in your cancer patients, and helping your clients’ beloved pets recover. You will also see less time wastage, and you will help clients save money because you can direct them, at a very early stage, toward cancer treatments that are data-validated.

Clients who observe excellent results from this AI-based treatment approach will be more inclined to consult you when new needs arise. As well, word of mouth will ensure an influx of new clients heading your way, resulting in higher income.

Personalized treatments will inevitably improve clinical outcomes, and benefit your practice by giving your clinical success rate a boost. As a result, relationships with clients will be strengthened, which always translates to a flourishing veterinary clinic.

TRAINING REQUIREMENTS

You need to be familiar with the Fine Needle Aspiration (FNA) method for sample collection. You can easily get a refresher regarding FNA by visiting the FAQ section on ImpriMed’s website.

In the News

How Artificial Intelligence Is Revolutionising Cancer Care for Pets

Pets Magazine
Learn More →

Artificial Intelligence Takes on Cancer: The Only AI Dr. Karyn Doesn’t Hate

Dogster
Learn More →

Comparative Oncology: Advances in Cancer Care from Pets to Humans

Pharmacy Times
Learn More →

Cancer Treatment Gets Personal: How Artificial Intelligence Is Taking the Guesswork Out of Common Canine Cancers

Dogster
Learn More →

Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans

Biopharma Boardroom
Learn More →

From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology

Pharmacy Times
Learn More →

ImpriMed unveils cancer treatment forecast technology

MobiHealthNews
Learn More →

New research evaluates flow cytometry and PARR as diagnostic support for feline lymphoma

American Animal Hospital Association NEWStat®
Learn More →

Cell-sizing method for high-accuracy feline lymphoma characterisation in veterinary sciences

Veterinary Practice
Learn More →

Flow cytometry and clonality evaluation are effective for characterizing feline lymphoma

DVM360
Learn More →

ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases In A $1+ Billion Market

Pulse 2.0
Learn More →

New AI Tool Guides Canine Cancer Treatment

Today's Veterinary Business
Learn More →

Artificial intelligence poised to transform veterinary care

AVMA News
Learn More →

New AI service offers personalized drug response predictions for canine patients with cancer

DVM360
Learn More →

Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

TechCrunch
Learn More →

ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment

USA Today
Learn More →

Data Science Can Markedly Improve Cancer Treatment Outcomes — ImpriMed Shows You How

Innovative Veterinary Care Journal
Learn More →

How ImpriMed Can Help Increase Cancer Remissions, Grow Your Reputation and Level Up Your Revenue

Innovative Veterinary Care Journal
Learn More →

ImpriMed: A Breath of Fresh Air for Traditionally Onerous Cancer Treatment Journeys

Innovative Veterinary Care Journal
Learn More →

ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization

International Business Times
Learn More →

The latest and greatest in canine oncology treatment

DVM360
Learn More →

Get Rid of Your Cancer Treatment Frustrations

Innovative Veterinary Care Journal
Learn More →

Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator

MedCity News
Learn More →

Be sure to improve your cancer treatment outcomes

Innovative Veterinary Care Journal
Learn More →

Early leukemia and lymphoma remissions in cats and dogs

Innovative Veterinary Care Journal
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 3)

One Million by One Million
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 2)

One Million by One Million
Learn More →

Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 1)

One Million by One Million
Learn More →

Technological advancement makes cancer treatment easier

Innovative Veterinary Care Journal
Learn More →

Novel veterinary oncologic treatments and diagnostics

dvm360
Learn More →

AI’s Computing Power Could Make Fusion Energy Practical

Lifewire
Learn More →

Don't Guess Your Pet's Condition, Treat It with ImpriMed

Startup to Follow
Learn More →

Interview with ImpriMed CEO & Co-Founder Sungwon Lim

IdeaMensch
Learn More →

This Test Might Make All The Difference When Fighting Lymphoma

Canine Cancer Alliance
Learn More →

ImpriMed: Fighting Cancer — From Dogs To Humans

Startup Thread
Learn More →

At Pear demo day, a who’s who of VCs, and plenty of fresh ideas

TechCrunch
Learn More →